Amicus Therapeutics' wound treatment fails late-stage trial
IN -

(Reuters) - U.S. drug developer Amicus Therapeutics Inc said on Wednesday its drug to treat wounds failed to meet the main goals of a late-stage clinical trial.

Loading...

Related Articles